tiprankstipranks
APONTIS PHARMA AG (DE:APPH)
:APPH
Germany Market

APONTIS PHARMA AG (APPH) Income Statement

Compare
6 Followers

APONTIS PHARMA AG Income Statement

Last quarter (Q2 2024), APONTIS PHARMA AG's total revenue was €22.73M, a decrease of -19.15% from the same quarter last year. In Q2, APONTIS PHARMA AG's net income was €702.80K. See APONTIS PHARMA AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 36.96M€ 55.73M€ 51.18M€ 39.24M€ 40.04M
Gross Profit
€ 23.17M€ 34.99M€ 33.79M€ 25.03M€ 28.97M
Operating Expenses
€ 23.17M€ 31.18M€ 32.12M€ 25.64M€ 31.21M
Depreciation and Amortization
€ 1.88M€ 1.80M€ 1.75M€ 1.65M€ 569.66K
EBITDA
€ -12.94M€ 5.67M€ 1.99M€ 1.04M-
Operating Income
€ -15.10M€ 5.67M€ 1.67M--
Other Income/Expenses
€ 253.71K€ 15.94K€ -1.42M--
Pretax Income
-€ 3.83M€ 248.26K--
Net Income
€ -11.30M€ 2.69M---
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ -1.33€ 0.32€ -0.09€ -0.14€ -0.28
Diluted EPS
€ -1.33€ 0.32€ -0.09€ -0.14€ -0.28
Weighted Average Shares Outstanding
8.50M 8.50M 8.50M 8.50M 8.50M
Weighted Average Shares Outstanding (Diluted)
8.50M 8.50M 8.50M 8.50M 8.50M
Currency in EUR

APONTIS PHARMA AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis